The use of integrated frequency ABC/VEN-analysis of application of medicines for the treatment of influenza and its complications in the hospital

• Main Authors: M. V. Leleka, L. L. Davtyan, O. M. Zaliska, S. Yu. Kit
• Format: Article
• Language: Ukrainian
• Published: The State Expert Center of the Ministry of Health of Ukraine 2019-05-01
• Series: Фармацевтичний журнал
• Subjects: integrated frequency ABC/VEN-analysis; medicines; influenza; acute respiratory infections; inpatient treatment
• Online Access: https://pharmj.org.ua/index.php/journal/article/view/486/456

The problem of limiting and rational use of funds in the health care system is relevant worldwide. Influenza and acute respiratory viral infections are cause of a lot of discussion about the treatment and prevention of the disease. The aim of the work ‒ to conduct an analysis of the data of the actual practice of appointment for patients with severe forms of influenza and its complications that were hospitalized at the hospital of the Lviv Regional Infectious Diseases Clinical Hospital. For the analysis of data of real practice of appointments were included data of 260 medical cards of patients of the Lviv Regional Infectious Clinical Hospital, which were hospitalized in 2016–2017 years with the diagnosis of influenza and SARI. We used statistical methods, real world evidence analysis, integrated frequency ABC/VEN analysis. The results of the VEN analysis indicate that in this department pharmacotherapy performs according to the current Protocols for medical care. Integrated frequency, VEN and ABC analysis showed that the leader of applications is Reosorbilact (the rate of expenses is 19%, the frequency of applications – 14%, the percentage of patients to whom it was appointed is 85%). Very expensive antibiotic Tigacil followed them, the next medicines in this list – Xylat (a rate of of expenses 10%, a frequency of applications is 5%, a share of patients – 28%). By answering the question about use the funds for important and vitally necessary medication, we can see that the rate of expenses for medicines of category V is 88.99%, it means that there is a rational use of funds. Analyzing the frequency of using the most expensive drugs (the cost of antibiotics is 46% of the total cost of drugs), it would be advisable to study the possibility of replacing it with cheaper counterparts. In general, pharmacological therapy is clinically and economically viable, but requires further standardization, and the analysis shows possible ways to optimize it, and reminds us how dangerous are the complications of the influenza, and which resources are needed for their treatment.